Kezar Life Sciences, Inc. (KZR) Misses Q3 EPS by 246c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($2.78), $2.46 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Murphy Oil announces oil discovery offshore Côte d'Ivoire
• Meta pauses an AI training program that tracks employees' keystrokes after a companywide leak - Insider